Background illustration for clinical trials search

Paid Clinical Trials Chesapeake

Discover 376 paid clinical trials in Chesapeake, Virginia. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

A Study of Teclistamab in Combination With Daratumumab and Lenalidomide (Tec-DR) and Talquetamab in Combination With Daratumumab and Lenalidomide (Tal-DR) in Participants With Newly Diagnosed Multiple Myeloma

for
Multiple Myeloma
Location: Norfolk VA, Richmond VA, Fort Belvoir VA, Durham NC,
Sponsor: Janssen Research & Development, LLC

Sex: All

Age: 18+

Code: NCT05552222

Phase3, Recruiting

Safety Study for a Gamma Delta T Cell Product Used With Low Dose Radiotherapy in Patients With Locally Advanced or Metastatic NSCLC or Solid Tumors With Bone Metastases

for
Carcinoma, Non-Small-Cell Lung Cancer,
Location: Norfolk VA, Pittsburgh PA, Tyler TX, Beverly Hills CA
Sponsor: Kiromic BioPharma Inc.

Sex: All

Age: 18+

Code: NCT06069570

Phase1, Recruiting

CATALINA-2: A Clinical Study of TORL-1-23 in Platinum-resistant Ovarian Cancer.

for
Epithelial Ovarian Cancer, Primary Peritoneal,
Location: Norfolk VA, Annapolis MD, Durham NC, Philadelphia PA,
Sponsor: TORL Biotherapeutics, LLC

Sex: Female

Age: 18+

Code: NCT06690775

Phase2, Recruiting

Clinical Study of Ivonescimab for First-line Treatment of Metastatic NSCLC Patients

for
Non-Small Cell Lung Cancer
Location: Norfolk VA, Reston VA, Chapel Hill NC, Baltimore MD,
Sponsor: Summit Therapeutics

Sex: All

Age: 18+

Code: NCT05899608

Phase3, Recruiting

Study to Evaluate IMGS-001 Treatment in Patients With Relapsed or Refractory Advanced Solid Tumors

for
Solid Tumor
Location: Norfolk VA, Philadelphia PA, Pittsburgh PA, Edgewood KY,
Sponsor: ImmunoGenesis

Sex: All

Age: 18+

Code: NCT06014502

Phase1, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Study of Tucatinib and Doxil in Participants With Human Epidermal Growth Factor Receptor 2 Positive (HER2+) Metastatic Breast Cancer

for
Breast Cancer
Location: Norfolk VA, Columbia MD, Salem VA, Bensalem PA,
Sponsor: SCRI Development Innovations, LLC

Sex: All

Age: 18+

Code: NCT05748834

Phase2, Recruiting

Study of Rondecabtagene Autoleucel in Aggressive Large B-Cell Lymphoma

for
Relapsed Non-Hodgkin Lymphoma, Refractory Non-Hodgkin Lymphoma,
Location: Norfolk VA, Richmond VA, Washington D.C. DC,
Sponsor: Lyell Immunopharma, Inc.

Sex: All

Age: 18+

Code: NCT05826535

Phase1, Phase2, Recruiting

An Open-label Study Comparing Lutetium (177Lu) Vipivotide Tetraxetan Versus Observation in PSMA Positive OMPC.

for
Oligometastatic Prostate Cancer (OMPC)
Location: Norfolk VA, Greenville NC, Baltimore MD,
Sponsor: Novartis Pharmaceuticals

Sex: Male

Age: 18 - 70+

Code: NCT05939414

Phase3, Recruiting

Sacituzumab Tirumotecan (MK-2870) Plus Pembrolizumab Versus TPC in TNBC Who Did Not Achieve pCR (MK-2870-012)

for
Triple-Negative Breast Cancer
Location: Norfolk VA, Midlothian VA, Richmond VA,
Sponsor: Merck Sharp & Dohme LLC

Sex: All

Age: 18+

Code: NCT06393374

Phase3, Recruiting

Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)

for
High Grade Epithelial Ovarian Cancer,
Location: Norfolk VA, Fairfax VA, Rockville MD, Camden NJ,
Sponsor: Genmab

Sex: All

Age: 18+

Code: NCT05579366

Phase1, Phase2, Recruiting

Study of KITE-363 or KITE-753 in Participants With Relapsed and/or Refractory B-cell Lymphoma

for
Relapsed and/or Refractory B-cell Lymphoma
Location: Norfolk VA, Baltimore MD, New York NY, Hackensack NJ,
Sponsor: Kite, A Gilead Company

Sex: All

Age: 18+

Code: NCT04989803

Phase1, Phase2, Recruiting

Heated Intraperitoneal Chemotherapy Followed by Niraparib for Ovarian, Primary Peritoneal and Fallopian Tube Cancer

for
Stage III Ovarian Cancer, Stage IV Ovarian Cancer,
Location: Norfolk VA, Raleigh NC, Fairfax VA, Durham NC,
Sponsor: GOG Foundation

Sex: Female

Age: 18+

Code: NCT05659381

Phase3, Recruiting

A Phase 1/2 Study of Enzomenib (DSP-5336) in Patients With Acute Leukemia (Horizen-1)

for
Leukemia, Myeloid, Acute, Leukemia, Lymphocytic, Acute,
Location: Norfolk VA, Charlottesville VA, Fairfax VA,
Sponsor: Sumitomo Pharma America, Inc.

Sex: All

Age: 12+

Code: NCT04988555

Phase1, Phase2, Recruiting

Study of Arlocabtagene Autoleucel (BMS-986393) a GPRC5D-directed CAR T Cell Therapy in Adult Participants With Relapsed or Refractory Multiple Myeloma

for
Multiple Myeloma
Location: Norfolk VA, Chapel Hill NC, Philadelphia PA,
Sponsor: Juno Therapeutics, Inc., a Bristol-Myers Squibb Company

Sex: All

Age: 18+

Code: NCT06297226

Phase2, Recruiting

CRISPR-Edited Allogeneic Anti-CD19 CAR-T Cell Therapy for Relapsed/Refractory B Cell Non-Hodgkin Lymphoma (ANTLER)

for
Lymphoma, Non-Hodgkin, Relapsed Non Hodgkin Lymphoma,
Location: Norfolk VA, Richmond VA, Philadelphia PA, Morristown NJ,
Sponsor: Caribou Biosciences, Inc.

Sex: All

Age: 18+

Code: NCT04637763

Phase1, Recruiting

A Study Comparing the Efficacy and Safety of Zanidatamab to Trastuzumab, Each in Combination With Physician's Choice Chemotherapy, for the Treatment of Participants With Metastatic HER2-positive Breast Cancer

for
Metastatic HER2-positive Breast Cancer
Location: Norfolk VA, Washington D.C. DC, Fairfax VA,
Sponsor: Jazz Pharmaceuticals

Sex: All

Age: 18+

Code: NCT06435429

Phase3, Recruiting

Consolidation of First-Line MRD+ Remission With Cema-cel in Patients With LBCL

for
Large B-cell Lymphoma
Location: Norfolk VA, Charlottesville VA, Washington D.C. DC,
Sponsor: Allogene Therapeutics

Sex: All

Age: 18+

Code: NCT06500273

Phase2, Recruiting

A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract

for
Carcinoma, Transitional Cell, Urinary Bladder Neoplasms,
Location: Norfolk VA, Baltimore MD, East Brunswick NJ,
Sponsor: Eli Lilly and Company

Sex: All

Age: 18+

Code: NCT07218380

Phase3, Recruiting

Trial of Xaluritamig in Adults With Metastatic Castration-resistant Prostate Cancer

for
Metastatic Castration-resistant Prostate Cancer (mCRPC)
Location: Norfolk VA, Durham NC, Philadelphia PA, Pittsburgh PA,
Sponsor: Amgen

Sex: Male

Age: 18+

Code: NCT07493512

Phase1, Recruiting

A Phase III Trial of BNT324 Versus Docetaxel in Metastatic Castration-resistant Prostate Cancer

for
Metastatic Castration-resistant Prostate Cancer
Location: Norfolk VA, Fairfax VA, Rockville MD, White Plains NY,
Sponsor: BioNTech SE

Sex: Male

Age: 18+

Code: NCT07365995

Phase3, Recruiting